Trium Capital »

Augmedix shares owned by Trium Capital

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Trium Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 1.2M 2.35

More positions owned by Trium Capital

Spdr S&p 500 Etf Trust Tr Unit Put Option (SPY)
Kraneshares Csi China Intern Csi Chi Internet (KWEB)
Ishares China Large-cap Etf China Lg-cap Etf (FXI)
Vaneck Vietnam Etf Vaneck Vietnam (VNM)
Perficient (PRFT)
Southwestern Energy Company
Abbott Laboratories (ABT)
Otis Worldwide Corp (OTIS)
Accenture Plc-cl A Shs Class A (ACN)
Cme (CME)
UnitedHealth (UNH)
Mastercard Inc - A Cl A (MA)
Stryker Corporation (SYK)
Moody's Corporation (MCO)
Gra (GGG)

View all positions for Trium Capital

Top funds holding Augmedix

Redmile Group
Samjo Management
Citadel Advisors
Perkins Capital Management
Vanguard Group
Schonfeld Strategic Advisors
Balyasny Asset Management
Trium Capital
G2 Investment Partners Management
Luminus Management
Russell Investments
Parkman Healthcare Partners
American Financial Group
Geode Capital Management
Millennium Management

View all funds holding Augmedix